BIO-key® International, Inc. Presenting Fingerprint Biometric Technology Solutions at IBM Pulse 2013

WALL, NJ–(Mar 1, 2013) – BIO-key International, Inc. (OTCBB: BKYI), a global leader in fingerprint biometric identification solutions and advanced mobile credentialing and identity verification technologies, today reported that the company will present the latest advances for interoperable fingerprint authentication at Pulse 2013 (Booth T132). BIO-key’s fingerprint biometric technology integrated with ISAM ESSO, offers IBM customers the unique ability to authenticate on any device or platform based on a single enrollment.

BIO-key, an “IBM Ready for Security Intelligence Partner” technology, is utilized by enterprise customers as well as government agencies on a global basis. The company’s software achieved top scores for speed and accuracy in the most recent National Institute for Standards of Technology (NIST) biometric evaluation.

“Our partnership with IBM is highly valued because of their vast global influence,” stated Mike DePasquale, CEO, BIO-key. “IBM is focused on delivering the next level of security solutions to meet the demands of a technology marketplace that’s experiencing measurable growth and generating high volumes of Big Data.”

IBM customers utilize BIO-key technology in conjunction with ISAM ESSO to enhance security with the most convenient multi-factor authentication solution available. To extend the awareness and capabilities amongst the IBM technical and sales support team along with IBM resellers, IBM published a Redguide featuring BIO-key technology. Redguides are referred to by sales and technical support representatives seeking new solutions for IBM customers. View BIO-key Biometric Service Provider for IBM by visiting the following link:

“As desktops and laptop/notebook PC’s evolve to tablets and smartphones, BIO-key’s interoperable biometric solutions enable customers to authenticate seamlessly from any device and from a single enrollment in the cloud,” DePasquale added.

The Pulse event March 3rd – 6th at the MGM Grand, Las Vegas, Nevada offers BIO-key an opportunity to network and present to 8,000 IBM business partners and top industry analysts seeking to learn more about innovative solutions for security.

BIO-key is also participating in the Vivastream online social marketing forum which offers Pulse attendees the opportunity to connect with BIO-key executives and ask questions, submit requests and schedule meetings before and after the event.

Connect with BIO-key for Pulse 2013 here:


About BIO-key

BIO-key International, Inc., headquartered in Wall, New Jersey, develops and delivers 49853_Clipboard01advanced identification solutions to commercial and government enterprises, integrators, and custom application developers. BIO-key’s award winning, high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise applications. Our solutions are used in local embedded OEM products as well as some of the world’s largest identification deployments to improve security, guarantee identity, and help reduce identity theft. BIO-key’s technology is offered directly or by market leading partners around the world. (

Contact: BIO-key International, Inc., Scott Mahnken, 732-359-1113


BIO-key Safe Harbor Statement

Certain statements contained in this press release may be construed as “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 (the “Act”). The words “estimate,” “project,” “intends,” “expects,” “anticipates,” “believes” and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management’s beliefs, as well as assumptions made by, and information currently available to, management pursuant to the “safe-harbor” provisions of the Act. These statements are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of these statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue, our ability to develop new products and evolve existing ones, the impact on our business of the recent financial crisis in the global capital markets and negative global economic trends, our ability to attract and retain key personnel. For a more complete description of these and other risk factors that may affect the future performance of BIO-key International, Inc., see “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2011 and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. The Company also undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.